Evidence map›Paper›PMID 33040430›Full record

ArticleTransplant infectious disease : an official journal of the Transplantation Society2021

Successful liver transplantation in a patient recovered from COVID-19.

Abhay Dhand, Roxana Bodin, David C Wolf, Aaron Schluger, Christopher Nabors, Rajat Nog, Thomas Diflo, Seigo Nishida

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Transplant infectious disease : an official journal of the Transplantation Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Successful liver transplantation in patients with active SARS-CoV-2 infection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  3. Successful deceased donor liver transplantation in candidates with high MELD and ongoing positive SARS-CoV-2 PCR.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Article
  4. Article
  5. Review
  6. Pediatric living donor intestine transplant following an atypical complication of COVID-19: A unique case report from India.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  7. Review
  8. Review
  9. Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2021
    Review
  10. Article
  11. Article
  12. Early liver transplantation after COVID-19 infection: The first report.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  13. Successful liver transplantation in a patient recovered from COVID-19.Transplant infectious disease : an official journal of the Transplantation Society · 2021
    Article
  14. Successful liver transplantation immediately after recovery from COVID-19 in a highly endemic area.Transplant international : official journal of the European Society for Organ Transplantation · 2021
    Article
  15. Article
  16. COVID-19 and Effect on Liver Transplant.Current treatment options in gastroenterology · 2021
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Abhay DhandWestchester Medical Center, Valhalla, NY, USA.ORCID https://orcid.org/0000-0003-3527-1938
Roxana BodinWestchester Medical Center, Valhalla, NY, USA.
David C WolfWestchester Medical Center, Valhalla, NY, USA.
Aaron SchlugerWestchester Medical Center, Valhalla, NY, USA.
Christopher NaborsWestchester Medical Center, Valhalla, NY, USA.
Rajat NogWestchester Medical Center, Valhalla, NY, USA.
Thomas DifloWestchester Medical Center, Valhalla, NY, USA.
Seigo NishidaWestchester Medical Center, Valhalla, NY, USA.
Westchester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transplantation in potential candidates who have recently recovered from COVID-19 is a challenge with uncertainties regarding the diagnosis, multi-organ systemic involvement, prolonged viral shedding in immunocompromised patients, and optimal immunosuppression. A 42 year male with alcoholic hepatitis underwent a successful deceased donor liver transplantation 71 days after the initial diagnosis of COVID-19. At the time of transplant, he was SARS-CoV-2 PCR negative for 24 days and had a MELD score of 33. His post-operative course was complicated by acute rejection which responded to intense immune-suppression using T-cell depletion and steroids. He was discharged with normal end-organ function and no evidence of any active infection including COVID-19. Prospective organ transplant recipients who have recovered from COVID-19 can be considered for transplantation after careful pre-transplant evaluation, donor selection, and individualized risk-benefit analysis.

Indexed as

Liver TransplantationAcute DiseaseAdultAntilymphocyte SerumCOVID-19COVID-19 SerotherapyEnd Stage Liver DiseaseGlucocorticoidsGraft RejectionHepatitis, AlcoholicHumansImmunization, PassiveImmunosuppressive AgentsMaleSARS-CoV-2Severity of Illness IndexAntilymphocyte SerumGlucocorticoidsImmunosuppressive AgentsthymoglobulincoronavirusCOVID-19liver transplantation

Identifiers

PMID33040430
PMCPMC7646032
OpenAlexW3092234560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.